BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23853104)

  • 21. Activation and repression of cellular immediate early genes by serum response factor cofactors.
    Lee SM; Vasishtha M; Prywes R
    J Biol Chem; 2010 Jul; 285(29):22036-49. PubMed ID: 20466732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divergent Regulation of Actin Dynamics and Megakaryoblastic Leukemia-1 and -2 (Mkl1/2) by cAMP in Endothelial and Smooth Muscle Cells.
    Smith MC; Hudson CA; Kimura TE; White SJ; Sala-Newby GB; Newby AC; Bond M
    Sci Rep; 2017 Jun; 7(1):3681. PubMed ID: 28623279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cooperative antiproliferative effect of coordinated ectopic expression of DLC1 tumor suppressor protein and silencing of MYC oncogene expression in liver cancer cells: Therapeutic implications.
    Yang X; Zhou X; Tone P; Durkin ME; Popescu NC
    Oncol Lett; 2016 Aug; 12(2):1591-1596. PubMed ID: 27446476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the MKL1/actin signaling pathway induces hormonal escape in estrogen-responsive breast cancer cell lines.
    Kerdivel G; Boudot A; Habauzit D; Percevault F; Demay F; Pakdel F; Flouriot G
    Mol Cell Endocrinol; 2014 Jun; 390(1-2):34-44. PubMed ID: 24721635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of SRF-dependent gene expression by association of SPT16 with MKL1.
    Kihara T; Kano F; Murata M
    Exp Cell Res; 2008 Feb; 314(3):629-37. PubMed ID: 18036521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role for MKL1 in megakaryocytic maturation.
    Cheng EC; Luo Q; Bruscia EM; Renda MJ; Troy JA; Massaro SA; Tuck D; Schulz V; Mane SM; Berliner N; Sun Y; Morris SW; Qiu C; Krause DS
    Blood; 2009 Mar; 113(12):2826-34. PubMed ID: 19136660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
    Schmidt LJ; Duncan K; Yadav N; Regan KM; Verone AR; Lohse CM; Pop EA; Attwood K; Wilding G; Mohler JL; Sebo TJ; Tindall DJ; Heemers HV
    Mol Endocrinol; 2012 May; 26(5):716-35. PubMed ID: 22456196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction.
    Huang X; Yang N; Fiore VF; Barker TH; Sun Y; Morris SW; Ding Q; Thannickal VJ; Zhou Y
    Am J Respir Cell Mol Biol; 2012 Sep; 47(3):340-8. PubMed ID: 22461426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New hPSC-based human models to study pediatric Acute Megakaryoblastic Leukemia harboring the fusion oncogene RBM15-MKL1.
    Ayllón V; Vogel-González M; González-Pozas F; Domingo-Reinés J; Montes R; Morales-Cacho L; Ramos-Mejía V
    Stem Cell Res; 2017 Mar; 19():1-5. PubMed ID: 28412998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MKL1-induced lncRNA SNHG18 drives the growth and metastasis of non-small cell lung cancer via the miR-211-5p/BRD4 axis.
    Fan H; Yuan J; Li Y; Jia Y; Li J; Wang X; Li X
    Cell Death Dis; 2021 Jan; 12(1):128. PubMed ID: 33500406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The transcriptional regulator megakaryoblastic leukemia-1 mediates serum response factor-independent activation of tenascin-C transcription by mechanical stress.
    Asparuhova MB; Ferralli J; Chiquet M; Chiquet-Ehrismann R
    FASEB J; 2011 Oct; 25(10):3477-88. PubMed ID: 21705668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Filamin A interacts with the coactivator MKL1 to promote the activity of the transcription factor SRF and cell migration.
    Kircher P; Hermanns C; Nossek M; Drexler MK; Grosse R; Fischer M; Sarikas A; Penkava J; Lewis T; Prywes R; Gudermann T; Muehlich S
    Sci Signal; 2015 Nov; 8(402):ra112. PubMed ID: 26554816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An interaction between MKL1, BRG1, and C/EBPβ mediates palmitate induced CRP transcription in hepatocytes.
    Fan Z; Li N; Xu Z; Wu J; Fan X; Xu Y
    Biochim Biophys Acta Gene Regul Mech; 2019 Sep; 1862(9):194412. PubMed ID: 31356989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone acetyltransferase p300 promotes MKL1-mediated transactivation of catechol-O-methyltransferase gene.
    Liu Z; Luo X; Liu L; Zhao W; Guo S; Guo Y; Wang N; He H; Liao X; Ma W; Zhou H; Zhang T
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1002-10. PubMed ID: 24096006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pro-senescence therapy for hepatocellular carcinoma.
    Muehlich S; Gudermann T
    Aging (Albany NY); 2013 Sep; 5(9):639-40. PubMed ID: 24057649
    [No Abstract]   [Full Text] [Related]  

  • 36. Growth arrest and DNA damage 45G down-regulation contributes to Janus kinase/signal transducer and activator of transcription 3 activation and cellular senescence evasion in hepatocellular carcinoma.
    Zhang L; Yang Z; Ma A; Qu Y; Xia S; Xu D; Ge C; Qiu B; Xia Q; Li J; Liu Y
    Hepatology; 2014 Jan; 59(1):178-89. PubMed ID: 23897841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SIRT6 Depletion Suppresses Tumor Growth by Promoting Cellular Senescence Induced by DNA Damage in HCC.
    Lee N; Ryu HG; Kwon JH; Kim DK; Kim SR; Wang HJ; Kim KT; Choi KY
    PLoS One; 2016; 11(11):e0165835. PubMed ID: 27824900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repression of the estrogen receptor-alpha transcriptional activity by the Rho/megakaryoblastic leukemia 1 signaling pathway.
    Huet G; Mérot Y; Percevault F; Tiffoche C; Arnal JF; Boujrad N; Pakdel F; Métivier R; Flouriot G
    J Biol Chem; 2009 Dec; 284(49):33729-39. PubMed ID: 19826002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma.
    Iwagami Y; Huang CK; Olsen MJ; Thomas JM; Jang G; Kim M; Lin Q; Carlson RI; Wagner CE; Dong X; Wands JR
    Hepatology; 2016 Apr; 63(4):1213-26. PubMed ID: 26683595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.